Author:
Blaylock Jason M.,Ewers Evan C.,Bianchi Elizabeth J.,King David B.,Casimier Rosemary O.,Erazo Hector,Grieco Stephen,Lay Jenny,Peel Sheila A.,Modjarrad Kayvon,Beckett Charmagne G.,Okulicz Jason F.,Scott Paul T.,Hakre Shilpa
Abstract
ABSTRACTBackgroundThe evidence for an increased incidence of sexually transmitted infections (STIs) among patients utilizing HIV pre-exposure prophylaxis (PrEP) has been inconsistent. We assessed the risk of incident STI while on PrEP compared to periods off PrEP among military service members starting PrEP.MethodsIncidence rates of chlamydia, gonorrhea, syphilis, hepatitis C virus, and HIV were determined among military service members without HIV prescribed daily oral tenofovir disoproxil fumarate and emtricitabine for HIV PrEP from February 1, 2014 through June 10, 2016. Hazard ratios for incident STIs were calculated using an Anderson-Gill recurrent event proportional hazard regression model.ResultsAmong 755 male service members, 477 (63%) were diagnosed with incident STIs (overall incidence 21.4 per 100 person-years). In multivariate analysis, male service members had a significantly lower risk of any STIs (adjusted hazard ratio (aHR) 0.24, 95% CI 0.12-0.47) compared to periods off PrEP after adjustment for socio-demographic characteristics and reasons for initiating PrEP. However, when stratifying for site and type of infection, the risk of extragenital gonorrhea infection (pharyngeal: aHR 2.08, 95% CI 0.85-5.11; rectal: aHR 1.36, 95% CI 0.54-3.46) and extragenital chlamydial infection (pharyngeal: aHR 3.33, 95% CL 0.54-20.36; rectal: aHR 1.73, 95% CI 0.93-3.24) was greater on PrEP compared to off PrEP although these values did not reach statistical significance.ConclusionsThe data suggest entry into PrEP care reduced the overall risk of STIs. Service members engaged in PrEP services also receive more STI prevention counseling, which might contribute to decreases in STI risk while on PrEP.
Publisher
Cold Spring Harbor Laboratory
Reference27 articles.
1. Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations
2. Centers for Disease Control and Prevention. PrEP for HIV Prevention in the U.S. 2021; PrEP for HIV Prevention in the U.S. Accessed June 2, 2022.
3. Ending the HIV Epidemic
4. Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2015–2019.
5. Centers for Disease Prevention and Control. Sexually Transmitted Disease Surveillance 2019. Atlanta: U.S. Department of Health and Human Services;2021.